Evogene Ltd. · NASDAQ:EVGN
Evogene — Investor Presentation (February 2017)
32 slides from Evogene's investor presentation, Feb 6, 2017
Slide 1: Introduction to Evogene
Introduction to Evogene February 2017 Ofer Haviv, President & CEO
Slide 2: Safe Harbor statement
Safe Harbor statement 2 This presentation contains "forward-looking statements" relating to future events, and we may from time to time make other statements, regarding our outlook or expectations for future financial or operating results and/or other matters regarding or affecting Evogene Ltd. or i
Slide 3: Table of contents
Table of contents Introduction Our technologyApplications and product programsSummary of investment highlights 3
Slide 4: Introducing Evogene
Introducing Evogene 4 We are… A leading biotechnology company for the improvement of crop productivity and performance, addressing the world’s increasing demand for food, feed and fuel
Slide 5: Farmer's needs
Farmer’s needs 5 Farmer’s main inputs Fertilizers Agro-technical Seeds Ag-Chemicals Ag-Biologicals Precision tools Farmer’s target – maximize profit Increase crop yield Reduce loses from stresses Minimize input expenses
Slide 6: The opportunity: a dire need for innovation
6 The opportunityA dire need for innovation Crops’ full yield potential - yet to be captured Insect control - resistance to available commercial traits Extra yield of up to 60% - significant potential yet to be capturedResistance to available commercial solutions Emerging as promising tool to drive
Slide 7: Evogene 'at a glance'
Evogene 'at a glance’ 7 An innovative, predictive discovery technology - applied to identify:Genetic elements for improved seedsChemical compounds for innovative Ag-ChemicalsMicrobes for novel Ag-BiologicalsStrategic collaborations with world-leading agriculture companies - including BASF, Bayer, Du
Slide 8: Our revenue & business models
Our revenue & business models 8 R&D payments R&D funding by partner Milestone fees Additional payments received upon achieving predetermined objectives Royalties Percentage of product sales by partner Collaboration timeline Early collaboration model Collaboration prior to initiating product discover
Slide 9: Value creation per product program
Value creation per product program 9 Collaboration timeline Advanced development & registration Discovery Early development Commercialization RD M M M R E L1 L2 Value (illustration) Over 10 majorproduct programs
Slide 10: Table of contents
Table of contents Introduction Our technologyApplications and product programsSummary of investment highlights 10
Slide 11: Technology platform
11 Technology platform Interconnected Data HubComputational integration of ‘Big Data’ - currently four interconnected databases Science Multidisciplinary scientific approachdriving our R&D Dedicated ‘Big Data’On-going accumulation - public resources and problem-tailored experiments Driving Ag Innova
Slide 12: Plant validation systems
12 Plant validation systemsProviding proof for our predictions
Slide 13: Technology platform: Implementation pathways
13 Technology platformImplementation pathways 13 Innovative discovery technology Improved Seeds InnovativeAg-Chemicals NovelAg-Biologicals Geneticelements Microbes Chemical compounds Platform outputs: Basis for development of innovative products
Slide 14: Table of contents
Table of contents Introduction Our technologyApplications and product programsSummary of investment highlights 14
Slide 15: Application pathways
15 15 Innovative discovery technology Improved Seeds InnovativeAg-Chemicals NovelAg-Biologicals Geneticelements Microbes Chemical compounds Platform outputs: Basis for development of innovative products Application pathways
Slide 16: Improved seeds - market and unmet needs
Improved seeds - market and unmet needs 16 ~$37B* in 2015 Innovation potential Basic seed Seed traits $0.5B $3.2B Insect resistance $1.5B $3.5B Herbicide tolerance $1.2B $1.5B Yield $0.45B $0.65B Drought tolerance $1B $1B Disease resistance Corn Soy Examples – trait values Existing Products Potentia
Slide 17: Improved seeds - activities and achievements
17 Improved seeds - activities and achievements Product trait programs - focus on corn, soy, wheat, cotton and canola Yield and abiotic stress – since 2004Disease resistance - since 2007Insect resistance – since 2014Main achievements - Most advanced gene in Phase II of developmentCollaborations with
Slide 18: Improved seeds - selected results
18 Improved seeds - selected results Genes demonstrated potential to achieve yield enhancement in target crops Additional optimization & development towards phase 2 Pathforward Further optimization and validation in plants towards licensing agreement Yield Insect resistance (internal program) Abioti
Slide 19: Improved seeds - upcoming value drivers
19 Improved seeds - upcoming value drivers Improvedseeds Trait Gene advancement - Gene advancement within early development (phase 1)Gene advancement to advanced development (phase 2) Toxin advancement - optimization and licensing -Entry into strategic, product development collaborationToxin advance
Slide 20: Application pathways
20 Application pathways 20 Innovative discovery technology Improved Seeds InnovativeAg-Chemicals NovelAg-Biologicals Geneticelements Microbes Chemical compounds Platform outputs: Basis for development of innovative products
Slide 21: Innovative Ag-Chemicals - market and unmet needs
21 ~$37B* in 2015 Innovation potential Key challenge - finding the next generation of novel herbicide Herbicides Insecticides Fungicides Others Glyphosate - leading herbicide with >$5B sales, yet broadly increasing weed resistance Dire need for novel herbicides due to increasing resistance Source -
Slide 22: Innovative Ag-Chemicals - activities & achievements
Innovative Ag-Chemicals - activities & achievements Product programs – Novel herbicides with new Mode of Action (MOA) - since 2013Main achievements – Strategic collaboration with BASF (signed in 2015)Discovery and validation in plants of several novel herbicide targets Tens of discovered small molec
Slide 23: Innovative Ag-Chemicals - selected results
Targets successfully validated in plants Chemicals displayed herbicide activityagainst weeds Innovative Ag-Chemicals - selected results 23 Advancement of targets and chemical hits – optimization and additional plant testing Path forward *Prior to optimization * Results from Evogene’s internal activi
Slide 24: Innovative Ag-Chemicals - upcoming value drivers
Innovative Ag-Chemicals - upcoming value drivers 24 InnovativeAg-Chemicals Product Discovery Early Development Advanced development & registration Commercialization Chemical hit advancement - Advanced hits - following optimization Initial leads - optimized hits with desired plant efficacy Collaborat
Slide 25: Application pathways
25 Application pathways 25 Innovative discovery technology Improved Seeds InnovativeAg-Chemicals NovelAg-Biologicals Geneticelements Microbes Chemical compounds Platform outputs: Basis for development of innovative products
Slide 26: Novel Ag-Biologicals - market and potential
26 ~$3.2B* in 2015 Innovation potential Development of “next generation” Ag-Biological products * Source: Phillips McDougall , 2015 ~$9B ~$3.2B E Source – 2020 estimation based on integrated information of BCC Research, marketsandmarkets, Agropages and Phillips McDougall Relatively short time and lo
Slide 27: Novel Ag-Biologicals - activities and achievements
27 Novel Ag-Biologicals - activities and achievements Product programs - Bio-stimulant (mainly yield and abiotic stress) in corn, soy and wheat – since 2015Main achievements - 10’s of microbes showing consistent improvement of yield traits in greenhouse and fieldEstablishment infrastructure for prod
Slide 28: Novel Ag-Biologicals - selected results
28 Novel Ag-Biologicals - selected results 10’s of microbial Hits displaying positive results in corn field trials EVO-0685 No treatment Example: EVO-0685 – improved ear size and weight at harvest resulted with 17% increase of yield per plant Combination of microbial hits, additional testing along w
Slide 29: Novel Ag-Biologicals - upcoming value drivers
Novel Ag-Biologicals - upcoming value drivers Product Discovery Early Development Advanced development & registration Commercialization Bio-stimulants Bio-pesticides Progress to advanced development - Advance Hits to Leads based on consortia (microbial team)Field testing & optimization development a
Slide 30: Table of contents
Table of contents Introduction Our technologyApplications and product programsSummary of investment highlights 30
Slide 31: Investment highlights
Investment highlights 5 2 3 4 Strong balance sheet 1 Engine for next generation product development targeting multi-billion dollar ag markets Unique technology platform, combining expertise in plant science and cutting-edge computational tools Diversified product portfolio with multiple paths to mil
Slide 32: Thank you
Thank you. Contact:[email protected]: +972 8 931 1964